42
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker

, , , , , & show all
Pages 129-135 | Published online: 23 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Koichi Sawaki, Mitsuro Kanda & Yasuhiro Kodera. (2018) Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer. Expert Review of Gastroenterology & Hepatology 12:7, pages 657-670.
Read now

Articles from other publishers (12)

Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, Timo L.M. ten Hagen, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari & Mojtaba Falahati. (2023) HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response. Pharmacological Research 190, pages 106732.
Crossref
Keshen Wang, Xiangyan Jiang, Yanxian Ren, Zhijian Ma, Xiaocheng Cheng, Fan Li, Jingying Xiao, Zeyuan Yu & Zuoyi Jiao. (2020) The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis. BMC Gastroenterology 20:1.
Crossref
Qiuyun Wu, Lei Han, Wenwen Gui, Feng Wang, Weiwen Yan & Hua Jiang. (2020) MiR‐503 suppresses fibroblast activation and myofibroblast differentiation by targeting VEGFA and FGFR1 in silica‐induced pulmonary fibrosis. Journal of Cellular and Molecular Medicine 24:24, pages 14339-14348.
Crossref
Ju Huang, You-xiang Chen & Bo Zhang. (2019) IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2. Gastric Cancer 23:1, pages 23-38.
Crossref
Wenjing Li, Jun Li, Hong Mu, Meiqi Guo & Haixia Deng. (2019) MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway. Cancer Cell International 19:1.
Crossref
Ga Bin Park & Daejin Kim. (2019) MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells. Neoplasia 21:2, pages 206-215.
Crossref
Chiara Rosso. (2018) Role of miR-503 in gastric cancer. Panminerva Medica 60:4.
Crossref
Jian Wu, Fengxia Gao, Tao Xu, Xin Deng, Chao Wang, Xiaoyan Yang, Zhi Hu, Yang Long, Xuemei He, Guannan Liang, Delian Ren & Tianyang Dai. (2018) miR-503 suppresses the proliferation and metastasis of esophageal squamous cell carcinoma by triggering autophagy via PKA/mTOR signaling. International Journal of Oncology.
Crossref
Qin Le, Niu Jianhua, Mulati, Xi Yu & He Jiageng. (2017) Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker. Open Medicine 12:1, pages 266-270.
Crossref
Yue Zhang, Dong-Hui Guan, Rong-Xiu Bi, Jin Xie, Chuan-Hua Yang & Yue-Hua Jiang. (2017) Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget 8:33, pages 55489-55510.
Crossref
Yuantao Cui, Yuan Xue, Shangwen Dong & Peng Zhang. (2017) Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. Journal of International Medical Research 45:4, pages 1310-1317.
Crossref
Hu Wei, Chen Wen-Ming & Jiao Jun-Bo. (2017) Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer. Journal of International Medical Research 45:3, pages 1054-1060.
Crossref